97246 ⎘
Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Crystal structure and uses thereof
#602Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof
#603Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)
#604Solid forms of anti-EGFR antibodies
#605Aggrecanase structure
#606Crystal of a transporter-ligand complex and methods of use
#607Crystal structures of MK2 and uses thereof
#608Method for making β-secretase co-crystals complexed with a ligand
#609Method for designing surfaces
#610Ecdysone receptor ligand-binding domain structure
#611Crystalline VAP-1 and uses thereof
#612Cytokine polypeptides
#613Methionine aminopeptidase and methods of use
#614Glycogen synthase kinase-3 inhibitors
#615Three-dimensional structure of the catalytic domain of protein kinase c theta, methods and uses thereof
#616Protein crystal
#617Bcl-w structure and uses therefor
#618Protein Structure Determination
#619Variants and chemically-modified variants of phenylalanine ammonia-lyase
#620Carnitine palmitoyltransferase II crystals
#621CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTORS AND USES THEREOF IN THE DESIGN OR IDENTIFICATION OF Fc RECEPTOR MODULATOR COMPOUNDS
#622Crystal structure of erythrocyte binding domain of EBA-175
#623Crystallized structure of type IV collagen NC1 domain hexamer
#624Modified TRAP protein for producing nano-scale electrical devices, and a method for producing such a protein
#625HCV polymerase suitable for crystal structure analysis and method for using the enzyme
#626Structure-based selection and affinity maturation of antibody library
#627Generation and selection of protein library in silico
#628Cytokine receptor
#629EGR-EGFR complex
#630Crystal structure of the ITK kinase domain
#631Crystal structure of human Pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
#632Three-dimensional structure of DNA recombination/repair protein and use thereof
#633Catalytic domain of ADAM33 and methods of use thereof
#634Nuclear receptor ligands and ligand binding domains
#635Atomic structure of the catalytic domain for use in designing and identifying inhibitors of zap-70 kinase
#636Crystalline Neutrokine-alpha protein, method of preparation thereof, and method of use thereof
#6373-structure of a whole integrin $g(a) v$g(b) extracellular region and uses therefor
#638Selective resonance of bodily agents
#639Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
#640Method for crystallizing human GSK3 and novel crystal structure thereof
#641Method for site-specific protein modifications
#642Structure of a glucocorticoid receptor ligand binding domain comprising an expanded binding pocket and methods employing same
#643Spleen tyrosine kinase catalytic domain:crystal structure and binding pockets thereof
#644Essential fungal polynucleotides, polypeptides, and methods of use
#645Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto
#646Subtilases
#647Crystal structure of phosphodiesterase 5 and use thereof
#648Crystal structures of YHHF polypeptides
#649G protein-coupled receptor structural model and a method of designing ligand binding to g protein-coupled receptor by using the structural model
#650Crystal structure of liganded cFMS kinase domain
#651PEGylated TNF-α variant proteins
#652Crystal structures of aspartate semialdehyde dehydrogenases
#653Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity
#654Crystallization of IGF-1
#655Resistant-repellent retroviral protease inhibitors
#656Crystallization of IGF-1
#657Crystallization of IGF-1
#658Crystallization of IGF-1
#659Crystallization of IGF-1
#660Polynucleotide encoding a mutant transglutaminase
#661Molecule
#662Crystallization of IGF-1
#663Crystallized structure of estrogen related receptor gamma in complex with bisphenol A
#664Crystal structure of SNAP-25 in complex with botulinum neurotoxin and uses thereof
#665Purified polypeptides from
#666Resistance-repellent retroviral protease inhibitors
#667Switch-region: target and method for inhibition of bacterial RNA polymerase
#668Peptides for active anti-cytokine immunization
#669Crystals and structure of Synagis Fab
#670CNG2B: a novel human cyclic nucleotide-gated ion channel
#671Structure of a complex of retinoblastoma protein bound to e2f, and uses thereof
#672Polypeptide methods and means
#673Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides
#674AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
#675Controlled dissolution crosslinked protein in crystals
#676Crystal structure of chorismate synthase and uses thereof
#677One-dimensional QSAR models
#678Structure of the farnesoid X receptor ligand binding domain and methods of use therefor
#679Viral polymerase and modulation thereof
#680Peptides for diagnostic and therapeutic methods for celiac sprue
#681Crystal structure of worm NitFhit reveals that a Nit tetramer binds tow Fhit dimers
#682Polynucleotide encoding a novel cysteine protease of the calpain superfamily, CAN-12, and variants thereof
#683Method for the crystallization of human serum albumin
#684Murine IL-18 crystal structure
#685Computational method for designing enzymes for incorporation of amino acid analogs into proteins
#686Crystal structure of an angiotensin-converting enzyme (ACE) and uses thereof
#687Crystalline phosphatase and method for use thereof
#688Methods for the design of estrogen receptor ligands
#689Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors
#690Three-dimensional structures of HDAC9 and Cabin1 and compound structures and methods related thereto
#691Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
#692Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
#693IGF antagonist peptides
#694Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
#695Information processing system using base sequence relevant information
#696Methods of identifying and designing cell surface receptor inhibitors
#697Methods and compositions related to argonaute proteins
#698Crystals of glucokinase and methods of growing them
#699Methods and compositions for milieu-dependent binding of a targeted agent to a target
#700MODULATORS OF RIBOSOMAL FUNCTION AND IDENTIFICATION THEREOF
#701Method for crystallizing human beta secretase in complex with an inhibitor
#702Crystal structure of baff, and use thereof in drug design
#703Erbb4 co-crystal
#704Mitotic kinesin binding site
#705Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody
#706Methods and compositions for treating cellular proliferative diseases
#707Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase
#708Controlled dissolution crosslinked protein crystals
#709Structural models of carnitine acyltransferases and uses thereof
#710Crystal structure of the c-fms kinase domain: applications and use of heterologous substitutions of kinase insert domains for crystallization
#711ERK2 crystals
#712Crystal structures of NH3-dependent NAD synthetases
#713Novel purified polypeptides from Enterococcus faecalis
#714Crystal structures of bacterial thymidylate kinases
#715Novel purified hydroxymethylglutaryl-CoA reductases and structures thereof
#716Novel purified polypeptides from haemophilus influenzae
#717Determination of a phosphorylation site in PPIase domain of Pin1 and uses therefor
#718Design of progesterone receptor ligands
#719Rab9 protein crystal structures and methods for identifying Rab9 modulators
#720Crystal structures of bacterial guanylate kinases
#721Crystal structure of house dust mite allergen Der p 1
#722Structure-based modulators of B1 G-protein coupled receptors
#723Glycogen synthase kinase-3 inhibitors
#724Crystal structure of the complex of hepatocyte growth factor beta chain with Met receptor and methods of use
#725AI-2 compounds and analogs based on LsrB structure
#726Antibodies against human interleukin-13 and pharmaceutical compositions thereof
#727Crystals of the Fc region of immunoglobulin epsilon heavy chain protein
#728Anticalins
#729Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1
#730Crystal of bacterial core RNA polymerase and methods of use thereof
#731Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof
#732Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics
#733Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
#734Three-dimensional structure of c-Abl
#735Crystal structure of interleukin-2 tyrosine kinase (ITK) and binding pockets thereof
#736Position dependent recognition of GNN nucleotide triplets by zinc fingers
#737Position dependent recognition of GNN nucleotide triplets by zinc fingers
#738Three-dimensional structure of complement receptor type 2 and uses thereof
#739Complexes of protein crystals and ionic polymers
#740Crystal structure of the hepatocyte growth factor and methods of use
#741Novel purified polypeptides from enterococcus faecalis
#742Structure of protein kinase C theta
#743Subunit vaccine against West Nile viral infection
#744Cold shock inducible expression and production of heterologous polypeptides
#745Ribosome structure and protein synthesis inhibitors
#746Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
#747Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
#748Three-dimensional structure of dipeptidyl peptidase IV
#749Crystal structure of the mitochondrial protoporphyrinogen IX oxidase
#750Modified G-CSF polypeptide
#751Drug therapy for celiac sprue
#752Three-dimensional structure of prostaglandin D synthase and utilization thereof
#753Novel purified polypeptides from Pseudomonas aeruginosa
#754Variant aldolase and processes for producing an optically active IHOG and an optically active monatin using the same
#755Peptidyl-tRNA hydrolase of Enterococcus faecalis
#756Solution phase biopanning method using engineered decoy proteins
#757Ribosome structure and protein synthesis inhibitors
#758Human cyclic nucleotide-gated cation channel polypeptide
#759Crystal structure of ribosomal protein L11/GTPase activating region rRNA and uses thereof
#760Methods and compositions comprising bacteriophage nanoparticles
#761Novel purified polypeptides from pseudomonas aeruginosa
#762Method for identifying or screening anti-viral agents
#763Crystallization of IGF-1
#764Novel purified polypeptides from streptococcus pneumoniae
#765Small and intermediate conductance, calcium-activated potassium channels and uses thereof
#766Novel purified polypeptides from bacteria
#767Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling or related proteins
#768Crystal structure of staphylococcus undecaprenyl pyrophosphate synthase and uses thereof
#769Compositions and methods for hydroxylating epothilones
#770Peptides that bind to broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex. uses thereof, compositions therefrom
#771Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof
#772Method of screening drug
#773Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE10A) and uses thereof
#774Crystal structure
#775Crystalline structure of oxidosqualene synthase
#776Crystal structure of VEGFRKD: ligand complexes and methods of use thereof
#777Crystal structure of the BTK kinase domain
#778Products and processes for modulating peptide-peptide binding domain interactions
#779Novel purified polypeptides from Streptococcus pneumoniae
#780Three-dimensional model of a Fc region of an IgE antibody and uses thereof
#781Structure-based design and synthesis of FGF inhibitors and FGF modulator compounds
#782Method of rational-based drug design using osteocalcin
#783Crystal structure of FMS-like tyrosine kinase
#784Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
#785Crystal structure
#786Three dimensional coordinates of melanocortin-4 receptors
#787Three dimensional coordinates of melanin-concentrating hormone receptors
#788PYK2 crystal structure and uses
#789Oligomerization of hepatitis delta antigen
#790Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha)
#791Novel purified polypeptides from staphylococcus aureus
#792Novel purified polypeptides from pseudomonas aeruginosa
#793Crystal structure of cytochrome P450
#794Novel purified polypeptides from Streptococcus pneumoniae
#795Crystal structure of the 30S ribosome and its use
#796Maleic acid salt of(2s)-n-{5-[amino(imino)methy]-2-thienyl}methyl-1-{(2r)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for
#797Inhibition of immune complex formation
#798Structure-based construction of human antibody library
#799Method and apparatus for generating biologically-active-substance candidate structure, and computer product
#800Crystal structure of aurora-2 protein and binding pockets thereof
#801Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same
#802Crystallisation of a GLP-1 analogue
#803STRUCTURE OF INTEGRIN ALPHA V-beta 3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND
#804Methods for rational pegylation of proteins
#805Crystalline forms(2s)-n-5[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2[(carboxymethyl) amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
#806Crystals and structures of protein kinase CHK2
#807Methods and apparatus for protein sequence analysis
#808Resistance-repellent retroviral protease inhibitors
#809Crystals and structures of c-Abl tyrosine kinase domain
#810Diagnosis and treatment of infectious diseases through indel-differentiated proteins
#811Polo domain structure
#812Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE1B) and uses thereof
#813Crystal of bacterial core RNA polymerase with rifampicin and methods of use thereof
#814PDE5A crystal structure and uses
#815S8 rRNA-binding protein from the small ribosomal subunit of
#816Crystal structure of glutamate racemase (MurI)
#817Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereof
#818Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
#819Method of identifying molecules that bind to the large ribosomal subunit
#820Mutants of igf binding proteins and methods of production of antagonists thereof
#821Crystal structure of cytochrome P450
#822Computer-based methods of designing molecules
#823Method for the prediction of binding targets and the design of ligands
#824Carboxyltransferase domain of acetyl-CoA carboxylase
#825Structures and methods for designing topoisomerase I inhibitors
#826Hepatitis C Virus NS5B polymerase inhibitor binding pocket
#827N-TRADD active site and uses thereof
#828C.difficile toxin B CROP domain peptides, antibodies and complexes thereof
#829Human growth hormone crystals and methods for preparing them